Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now official registry

Diabetes Complications clinical trials

Every US clinical trial registered for Diabetes Complications — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

11 US clinical trials · 6 currently recruiting

The research picture

Diabetes Complications has 11 registered US clinical trials, 6 of them open to new participants right now — about 55% of the total.

6
recruiting participants now
55%
of trials open to enrollment
1
in Phase 3–4 (later-stage)
3
top sponsor: University of Colorado, Denver

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING Phase 1 5,000 participants

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Thomas Advanced Medical

NCT04684602

RECRUITING NA 140 participants

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

Boston Medical Center

NCT06236607

RECRUITING NA 120 participants

Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers

Johns Hopkins University

NCT05579743

RECRUITING NA 120 participants

A Fruit and Vegetable Prescription Program

Milton S. Hershey Medical Center

NCT06107816

RECRUITING 100 participants

Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)

University of Colorado, Denver

NCT05319990

RECRUITING 20 participants

Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy

University of Alabama at Birmingham

NCT03403699

ACTIVE NOT RECRUITING NA 60 participants

Electronic Diabetes Tune-Up Group (eDTU) for African Americans

Indiana University

NCT06321029

COMPLETED Phase 1 39 participants

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Goldfinch Bio

NCT04880291

COMPLETED Phase 1 24 participants

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

University of Colorado, Denver

NCT03620773

COMPLETED Phase 3 16 participants

A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community

Northwestern University

NCT01695278

COMPLETED Phase 2 10 participants

Evaluation of Coffee Therapy for Improvement of Renal Oxygenation

University of Colorado, Denver

NCT03878277

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 1
Phase 3 1

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Diabetes Complications Trial Landscape

ClinicalTrials.gov lists 11 US studies indexed under Diabetes Complications, and 6 of those are currently open to recruitment — roughly 55% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Diabetes Complications shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 4 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Diabetes Complications is led by University of Colorado, Denver with 3 indexed trials, alongside 8 other organizations in the top contributor list. The list on this page surfaces up to 11 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Diabetes Complications?

PlainTrial tracks 11 US clinical trials for Diabetes Complications, of which 6 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Diabetes Complications?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →